A Phase II Study of SI-613 in Patients with Knee Osteoarthritis

Trial Profile

A Phase II Study of SI-613 in Patients with Knee Osteoarthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2014

At a glance

  • Drugs SI 613 (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Seikagaku Corporation
  • Most Recent Events

    • 28 Jan 2014 According to University Hospital Medical Information Network - Japan record (UMIN000010167) study status has changed from active, no longer recruiting to completed.
    • 28 Jan 2014 According to University Hospital Medical Information Network - Japan record (UMIN000010167) actual initiation date changed from 7 Feb 2013 to 21 Mar 2013.
    • 05 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top